Sopharma Trading AD

BUL:SFT Stock Report

Market Cap: лв197.1m

Sopharma Trading AD Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Sopharma Trading AD.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth24.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

We're Not Counting On Sopharma Trading AD (BUL:SO5) To Sustain Its Statutory Profitability

Feb 14
We're Not Counting On Sopharma Trading AD (BUL:SO5) To Sustain Its Statutory Profitability

If You Had Bought Sopharma Trading AD's (BUL:SO5) Shares Three Years Ago You Would Be Down 27%

Dec 18
If You Had Bought Sopharma Trading AD's (BUL:SO5) Shares Three Years Ago You Would Be Down 27%

We Wouldn't Rely On Sopharma Trading AD's (BUL:SO5) Statutory Earnings As A Guide

Aug 10
We Wouldn't Rely On Sopharma Trading AD's (BUL:SO5) Statutory Earnings As A Guide

Sopharma Trading AD's (BUL:SO5) Shareholders Are Down 35% On Their Shares

Jul 20
Sopharma Trading AD's (BUL:SO5) Shareholders Are Down 35% On Their Shares

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sopharma Trading AD has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

BUL:SFT - Analysts future estimates and past financials data (BGN Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20241,770352744N/A
3/31/20241,72832-114N/A
12/31/20231,678303348N/A
9/30/20231,61992538N/A
6/30/20231,588132335N/A
3/31/20231,535103040N/A
12/31/20221,4839919N/A
9/30/20221,43821-60-50N/A
6/30/20221,41418-112-101N/A
3/31/20221,37813-149-136N/A
12/31/20211,3368-186-173N/A
9/30/20211,33315-222-219N/A
6/30/20211,26912-209-199N/A
3/31/20211,19012-212-203N/A
12/31/20201,15611-228-217N/A
9/30/20201,06810-208-181N/A
6/30/20201,01710-204-185N/A
3/31/20201,00211-216-194N/A
12/31/20199469-203-182N/A
9/30/20199298-188-174N/A
6/30/20199169-187-170N/A
3/31/20199019-167-154N/A
12/31/20188889-166-154N/A
9/30/20188668-154-143N/A
6/30/20188258-136-131N/A
3/31/20187768N/A-120N/A
12/31/20177219N/A-115N/A
9/30/201766910N/A-107N/A
6/30/201764210N/A-112N/A
3/31/201762611N/A-104N/A
12/31/201661311N/A-91N/A
9/30/201660210N/A-62N/A
6/30/201660411N/A-23N/A
3/31/201660311N/A6N/A
12/31/201560311N/A22N/A
9/30/201559812N/A9N/A
6/30/201558711N/A-4N/A
12/31/201457611N/A-5N/A
9/30/201456612N/A8N/A
6/30/201455012N/A-32N/A
3/31/201452911N/A-30N/A
12/31/20135079N/A-30N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SFT's forecast earnings growth is above the savings rate (3%).

Earnings vs Market: Insufficient data to determine if SFT's earnings are forecast to grow faster than the BG market

High Growth Earnings: Insufficient data to determine if SFT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if SFT's revenue is forecast to grow faster than the BG market.

High Growth Revenue: Insufficient data to determine if SFT's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if SFT's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y